XtalPi Inc. (XtalPi), a leading technology platform company renowned for melding physics-based computation, artificial intelligence (AI), and robotics to advance the discovery and evolution of groundbreaking medicines and innovative materials, has announced the launch of a new facility in Shanghai, a strategic move to expand its capacity, addressing the rapidly rising demand for high-quality, efficient R&D outsourcing across diverse domains including drug and materials discovery. This Shanghai site is XtalPi's largest automation lab in China, surpassing the automation R&D lab of its headquarters in Shenzhen.

The facility is set to be fully operational by late Q3 2023, housing over 100 automated workstations and automation clusters. The initial areas of focus will be on serving drug discovery and pharmaceutical development projects. XtalPi now operates three global automation laboratories that serve partners across three major hubs: Shenzhen, Shanghai, and Boston.

The startup has also recently unveiled its newest brand, XtalPi Intelligent Automation in Shanghai, China.

XtalPi Intelligent Automation embodies XtalPi's vision to revolutionise modern laboratory automation solutions, reshaping the ecosystem of scientific exploration and addressing significant R&D challenges in multiple industrial sectors.